<a href=GSK” height=”149″ src=”https://www.drugdevelopment-technology.com/wp-content/uploads/static-progressive/nri/pharma/300px-GlaxoSmithKline_headquaters_-Brentford,_London,_England-2Oct2011.jpg” style=”padding: 10px” width=”300″ />

GlaxoSmithKline (GSK) has won the Outstanding Achievement in Chemical Engineering Award along with project partners GEA, Siemens, Sagentia and the Universities of Newcastle, Warwick and Surrey at the IChemE 2012 Awards.

The award was granted in appreciation to the organisation’s key change in the pharmaceutical manufacture process.

IChemE CEO David Brown said the range of award winners underscore the diversity of the profession.

"Chemical engineers are working all over the world on innovative projects and finding solutions to some of the biggest challenges facing society today – a growing demand for secure and sustainable energy, access to clean and plentiful water supplies, food and nutrition and societal health and wellbeing," Brown said.

"The IChemE Awards give us a platform to recognise some of the best work taking place all over the world throughout the chemical and process engineering community."

The organisation also won the Chemical Engineering Project of the Year Award for the change in tablet production from stepwise batch processing to a closely controlled process.

The fully integrated process ensures consistency, improves the process equipment footprint and has cut cost by 20%.

GlaxoSmithKline’s new tablet-manufacturing process, liquid dispensing technology (LDT), won the company the Health and Safety Award.

Image: GlaxoSmithKline has won the Outstanding Achievement in Chemical Engineering Award. Photo: Maxwell Hamilton.